Autism biomarker seen as boon for new treatments

January 10, 2017

Researchers at the UCLA Center for Autism Research and Treatment have identified a signature brain-wave pattern for children with autism spectrum disorder related to a genetic condition known as Dup15q syndrome. The researchers acquired EEG recordings from participants and analyzed EEG beta wave oscillations among children with autism, typically developing children and children with Dup15q syndrome. As a result of this analysis, the team identified a quantitative biomarker for individuals with autism spectrum disorder and Dup15q syndrome. This biomarker is among the first few quantitative biomarkers for autism spectrum disorder and Dup15q syndrome. This exciting discovery could lead to more targeted clinical care and early diagnosis.


Read more at UCLA Newsroom